Skip to main content
Erschienen in: Brain Structure and Function 7/2020

26.06.2020 | Original Article

Direct administration of ifenprodil and citalopram into the nucleus accumbens inhibits cue-induced nicotine seeking and associated glutamatergic plasticity

verfasst von: Jonna M. Leyrer-Jackson, Jose A. Piña, Joseph McCallum, M. Foster Olive, Cassandra D. Gipson

Erschienen in: Brain Structure and Function | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Abstract

Nicotine use disorder has been associated with glutamatergic alterations within the basal ganglia that might contribute to relapse. Specifically, initiation of cue-induced nicotine seeking produces rapid, transient synaptic potentiation (t-SP) in nucleus accumbens core (NAcore) medium spiny neurons (MSNs), defined as increases in spine head diameter and AMPA to NMDA current ratios (A/N). Ifenprodil, which inhibits nicotine reinstatement when administered systemically, antagonizes GluN2B-containing NMDA receptors, has affinity for serotonin receptors, and blocks serotonin transporters (SERT). The mechanisms underlying its therapeutic efficacy, however, remain unknown. Using pharmacological and genetic approaches, the current study examined the role of NAcore GluN2B receptors as well as SERT in mediating cue-induced nicotine seeking and associated MSN structure and physiology. Prior to reinstatement, rats received intra-NAcore injections of either ifenprodil, citalopram or artificial cerebral spinal fluid (15 min prior), or GluN2B or control siRNAs (3 consecutive days prior). Rats were sacrificed after a 15-min cue-induced reinstatement session for dendritic spine analysis, western blotting or whole-cell electrophysiology. Intra-NAcore ifenprodil blocked nicotine-seeking behavior and promoted a higher frequency of shorter spines on MSN dendrites. However, a decrease in membrane-bound GluN2B receptor expression did not prevent cue-induced nicotine seeking or associated MSN cell physiology. Interestingly, intra-NAcore citalopram, an SSRI, prevented cue-induced nicotine seeking. Together, these results indicate that the therapeutic effects of ifenprodil on cue-induced nicotine seeking may, in part, be due to its actions at SERT rather than GluN2B, which may be specific to nicotine-seeking as opposed to other drugs of abuse.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Bezchlibnyk-Butler K, Aleksic I, Kennedy SH (2000) Citalopram—a review of pharmacological and clinical effects. J Psychiatry Neurosci 25(3):241–254PubMedPubMedCentral Bezchlibnyk-Butler K, Aleksic I, Kennedy SH (2000) Citalopram—a review of pharmacological and clinical effects. J Psychiatry Neurosci 25(3):241–254PubMedPubMedCentral
Zurück zum Zitat Chen JP, van Praag HM, Gardner EL (1991) Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res 543(2):354–357CrossRef Chen JP, van Praag HM, Gardner EL (1991) Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res 543(2):354–357CrossRef
Zurück zum Zitat De Sarro GB, Bagetta G, Spagnolo C, Nistico G (1993) Antagonists of N-methyl-D-aspartate receptors block seizures induced by putrescine in the deep prepiriform. Neuropharmacology 32(1):43–50CrossRef De Sarro GB, Bagetta G, Spagnolo C, Nistico G (1993) Antagonists of N-methyl-D-aspartate receptors block seizures induced by putrescine in the deep prepiriform. Neuropharmacology 32(1):43–50CrossRef
Zurück zum Zitat Dong Y, Nestler EJ (2014) The neural rejuvenation hypothesis of cocaine addiction. Trends Pharmacol Sci 35(8):374–383CrossRef Dong Y, Nestler EJ (2014) The neural rejuvenation hypothesis of cocaine addiction. Trends Pharmacol Sci 35(8):374–383CrossRef
Zurück zum Zitat Inoue T, Li XB, Abekawa T, Kitaichi Y, Izumi T, Nakagawa S, Koyama T (2004) Selective serotonin reuptake inhibitor reduces conditioned fear through its effect in the amygdala. Eur J Pharmacol 497(3):311–316CrossRef Inoue T, Li XB, Abekawa T, Kitaichi Y, Izumi T, Nakagawa S, Koyama T (2004) Selective serotonin reuptake inhibitor reduces conditioned fear through its effect in the amygdala. Eur J Pharmacol 497(3):311–316CrossRef
Zurück zum Zitat McCool BA, Lovinger DM (1995) Ifenprodil inhibition of the 5-hydroxytryptamine3 receptor. Neuropharmacology 34(6):621–629CrossRef McCool BA, Lovinger DM (1995) Ifenprodil inhibition of the 5-hydroxytryptamine3 receptor. Neuropharmacology 34(6):621–629CrossRef
Zurück zum Zitat Mineur YS, Picciotto MR (2009) Biological basis for the co-morbidity between smoking and mood disorders. J Dual Diagn 5(2):122–130CrossRef Mineur YS, Picciotto MR (2009) Biological basis for the co-morbidity between smoking and mood disorders. J Dual Diagn 5(2):122–130CrossRef
Zurück zum Zitat Paxinos G, Franklin KB (2013) The mouse brain in stereotaxic coordinates, 4th edn. Academic Press, Amsterdam, pp 31–231 Paxinos G, Franklin KB (2013) The mouse brain in stereotaxic coordinates, 4th edn. Academic Press, Amsterdam, pp 31–231
Zurück zum Zitat Shoaib M, Buhidma Y (2018) Why are antidepressant drugs effective smoking cessation aids? Current Neuropharmacol 16(4):426–437CrossRef Shoaib M, Buhidma Y (2018) Why are antidepressant drugs effective smoking cessation aids? Current Neuropharmacol 16(4):426–437CrossRef
Zurück zum Zitat Sim-Selley LJ, Selley DE, Vogt LJ, Childers SR, Martin TJ (2000) Chronic heroin self-administration desensitizes mu opioid receptor-activated G-proteins in specific regions of rat brain. J Neurosci 20(12):4555–4562CrossRef Sim-Selley LJ, Selley DE, Vogt LJ, Childers SR, Martin TJ (2000) Chronic heroin self-administration desensitizes mu opioid receptor-activated G-proteins in specific regions of rat brain. J Neurosci 20(12):4555–4562CrossRef
Zurück zum Zitat Stolerman IP, Jarvis MJ (1995) The scientific case that nicotine is addictive. Psychopharmacology 117(1):2–10 (discussion 14–20)CrossRef Stolerman IP, Jarvis MJ (1995) The scientific case that nicotine is addictive. Psychopharmacology 117(1):2–10 (discussion 14–20)CrossRef
Zurück zum Zitat Talbot JN, Geffert LM, Jorvig JE, Goldstein RI, Nielsen CL, Wolters NE, Amos ME, Munro CA, Dallman E, Mereu M, Tanda G, Katz JL, Indarte M, Madura JD, Choi H, Leak RK, Surratt CK (2016) Rapid and sustained antidepressant properties of an NMDA antagonist/monoamine reuptake inhibitor identified via transporter-based virtual screening. Pharmacol Biochem Behav 150–151:22–30. https://doi.org/10.1016/j.pbb.2016.08.007CrossRefPubMed Talbot JN, Geffert LM, Jorvig JE, Goldstein RI, Nielsen CL, Wolters NE, Amos ME, Munro CA, Dallman E, Mereu M, Tanda G, Katz JL, Indarte M, Madura JD, Choi H, Leak RK, Surratt CK (2016) Rapid and sustained antidepressant properties of an NMDA antagonist/monoamine reuptake inhibitor identified via transporter-based virtual screening. Pharmacol Biochem Behav 150–151:22–30. https://​doi.​org/​10.​1016/​j.​pbb.​2016.​08.​007CrossRefPubMed
Zurück zum Zitat Yoshimoto K, McBride WJ (1992) Regulation of nucleus accumbens dopamine release by the dorsal raphe nucleus in the rat. Neurochem Res 17(5):401–407CrossRef Yoshimoto K, McBride WJ (1992) Regulation of nucleus accumbens dopamine release by the dorsal raphe nucleus in the rat. Neurochem Res 17(5):401–407CrossRef
Metadaten
Titel
Direct administration of ifenprodil and citalopram into the nucleus accumbens inhibits cue-induced nicotine seeking and associated glutamatergic plasticity
verfasst von
Jonna M. Leyrer-Jackson
Jose A. Piña
Joseph McCallum
M. Foster Olive
Cassandra D. Gipson
Publikationsdatum
26.06.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Brain Structure and Function / Ausgabe 7/2020
Print ISSN: 1863-2653
Elektronische ISSN: 1863-2661
DOI
https://doi.org/10.1007/s00429-020-02103-9

Weitere Artikel der Ausgabe 7/2020

Brain Structure and Function 7/2020 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.